telmisartan has been researched along with Cardiac Remodeling, Ventricular in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Li, M; Liu, L; Tian, G; Zhu, D | 1 |
| Cai, Y; Chang, D; Ju, S; Lu, CQ; Min, SD; Wang, YC; Xu, TT; Zhang, SJ; Zhao, Z | 1 |
| Gaikwad, AB; Malek, V | 1 |
| Chang, WT; Chen, ZC; Cheng, JT | 1 |
| Brazhnik, VA; Makolkin, VI; Petriĭ, VV; Sergushkina, NG | 1 |
| Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T | 1 |
| Hara, Y; Harada, T; Kikuzuki, R; Okada, M; Yamawaki, H | 1 |
| Aizawa, Y; Gurusamy, N; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Abe, N; Hanada, H; Hanada, K; Higuma, T; Kushibiki, M; Oikawa, K; Okumura, K; Osanai, T; Tomita, H; Yokota, T; Yokoyama, J | 1 |
| Haraguchi, G; Isobe, M; Kosuge, H; Maejima, Y; Okada, H; Onai, Y; Suzuki, J | 1 |
| Morozova, OI; Petrushin, IA; Pozdniakova, NV; Sekerko, SA; Tatarchenko, IP | 1 |
| Hirata, Y; Hishikari, K; Isobe, M; Masumura, M; Nagai, R; Nagashima, A; Ogawa, M; Shimizu, T; Suzuki, J; Takayama, K; Watanabe, R | 1 |
| Verdecchia, P | 1 |
| Babic, R; Dragicevic, J; Petrovic, D; Petrovic, I; Vasiljevic, Z; Vukovic, N; Zivanovic, B | 1 |
| Fukushima, H; Hirata, H; Kobayashi, N; Machida, Y; Mamada, Y; Matsuoka, H; Nomura, M; Ohno, T; Shinoda, M; Suzuki, N; Yoshida, K | 1 |
1 review(s) available for telmisartan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Pre-clinical and clinical experience of telmisartan in cardiac remodelling.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Telmisartan; Ventricular Remodeling | 2005 |
6 trial(s) available for telmisartan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Female; Fibrosis; Humans; Longitudinal Studies; Male; Middle Aged; Myocardium; Myocytes, Cardiac; PPAR gamma; Prospective Studies; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Streptozocin; Telmisartan; Time Factors; Translational Research, Biomedical; Treatment Outcome; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2016 |
[Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Organ Size; Telmisartan; Time Factors; Tunica Intima; Ventricular Remodeling | 2008 |
Beneficial effects of telmisartan on left ventricular structure and function in patients with hypertension determined by two-dimensional strain imaging.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Torsion, Mechanical; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Enalapril; Female; Humans; Inflammation Mediators; Japan; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Prospective Studies; Radiography; Serum Amyloid P-Component; Stroke Volume; Telmisartan; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2010 |
[Clinical- functional assessment of organoprotective efficacy of enalapril and telmisartan in patients with arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Echocardiography; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Vasodilation; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Carotid Arteries; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertension; Male; Middle Aged; Muscle, Smooth, Vascular; Ramipril; Retrospective Studies; Telmisartan; Time Factors; Tunica Intima; Tunica Media; Ventricular Remodeling | 2005 |
8 other study(ies) available for telmisartan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.
Topics: Animals; Antihypertensive Agents; Autocrine Communication; Hypertension; Leptin; Male; Myocardium; PPAR gamma; Rats; Rats, Sprague-Dawley; Telmisartan; Ventricular Remodeling | 2020 |
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardio-Renal Syndrome; Diastole; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Stroke Volume; Telmisartan; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.
Topics: Acetylation; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Therapy, Combination; Fibrosis; Histone Acetyltransferases; Histones; Male; Myocytes, Cardiac; Neprilysin; Protease Inhibitors; Protein Processing, Post-Translational; Rats, Wistar; Signal Transduction; Telmisartan; Thiorphan; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Echocardiography; Fibrosis; Histocytochemistry; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Myocardium; Organ Size; Rats; Rats, Wistar; Stroke Volume; Systole; Telmisartan; Transforming Growth Factor beta1; Ventricular Remodeling | 2009 |
Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Benzimidazoles; Benzoates; Cardiomyopathy, Dilated; Chronic Disease; Cytokines; Fibrosis; Heart Failure; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; Telmisartan; Ventricular Remodeling | 2010 |
Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Connective Tissue Growth Factor; Echocardiography; Enzyme Activation; Macrophages; Male; Metalloproteases; Myocardial Infarction; Natriuretic Peptide, Brain; Osteopontin; PPAR gamma; Rats; Rats, Sprague-Dawley; Survival Analysis; Telmisartan; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Ventricular Remodeling | 2011 |
Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Disease Models, Animal; Drug Partial Agonism; Fibrosis; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Stroke Volume; Telmisartan; Thiazolidinediones; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Collagen Type I; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Plasminogen Activator Inhibitor 1; PPAR gamma; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Inbred Dahl; Research Design; rho-Associated Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sodium Chloride, Dietary; Superoxides; Telmisartan; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2008 |